Cargando…

Glycaemic control and novel technology management strategies in pregestational diabetes mellitus

INTRODUCTION: Pregestational diabetes (PGDM) is an increasingly common and complex condition that infers risk to both mother and infant. To prevent serious morbidity, strict glycaemic control is essential. The aim of this review is to review the glucose sensing and insulin delivering technologies cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, Christine, Ero, Adesuwa, Dunne, Fidelma P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877346/
https://www.ncbi.nlm.nih.gov/pubmed/36714590
http://dx.doi.org/10.3389/fendo.2022.1109825
_version_ 1784878347532107776
author Newman, Christine
Ero, Adesuwa
Dunne, Fidelma P.
author_facet Newman, Christine
Ero, Adesuwa
Dunne, Fidelma P.
author_sort Newman, Christine
collection PubMed
description INTRODUCTION: Pregestational diabetes (PGDM) is an increasingly common and complex condition that infers risk to both mother and infant. To prevent serious morbidity, strict glycaemic control is essential. The aim of this review is to review the glucose sensing and insulin delivering technologies currently available for women with PGDM. METHODS: We reviewed online databases for articles relating to technology use in pregnancy using a combination of keywords and MeSH headings. Relevant articles are included below. RESULTS: A number of technological advancements have improved care and outcomes for women with PGDM. Real time continuous glucose monitoring (rtCGM) offers clear advantages in terms of infants size and neonatal intensive care unit admissions; and further benefits are seen when combined with continuous subcutaneous insulin delivery (insulin pump) and algorithms which continuously adjust insulin levels to glucose targets (hybrid closed loop). Other advancements including flash or intermittent scanning CGM (isCGM) and stand-alone insulin pumps do not confer as many advantages for women and their infants, however they are increasingly used outside of pregnancy and many women enter pregnancy already using these devices. DISCUSSION: This article offers a discussion of the most commonly used technologies in pregnancy and evaluates their current and future roles.
format Online
Article
Text
id pubmed-9877346
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98773462023-01-27 Glycaemic control and novel technology management strategies in pregestational diabetes mellitus Newman, Christine Ero, Adesuwa Dunne, Fidelma P. Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Pregestational diabetes (PGDM) is an increasingly common and complex condition that infers risk to both mother and infant. To prevent serious morbidity, strict glycaemic control is essential. The aim of this review is to review the glucose sensing and insulin delivering technologies currently available for women with PGDM. METHODS: We reviewed online databases for articles relating to technology use in pregnancy using a combination of keywords and MeSH headings. Relevant articles are included below. RESULTS: A number of technological advancements have improved care and outcomes for women with PGDM. Real time continuous glucose monitoring (rtCGM) offers clear advantages in terms of infants size and neonatal intensive care unit admissions; and further benefits are seen when combined with continuous subcutaneous insulin delivery (insulin pump) and algorithms which continuously adjust insulin levels to glucose targets (hybrid closed loop). Other advancements including flash or intermittent scanning CGM (isCGM) and stand-alone insulin pumps do not confer as many advantages for women and their infants, however they are increasingly used outside of pregnancy and many women enter pregnancy already using these devices. DISCUSSION: This article offers a discussion of the most commonly used technologies in pregnancy and evaluates their current and future roles. Frontiers Media S.A. 2023-01-12 /pmc/articles/PMC9877346/ /pubmed/36714590 http://dx.doi.org/10.3389/fendo.2022.1109825 Text en Copyright © 2023 Newman, Ero and Dunne https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Newman, Christine
Ero, Adesuwa
Dunne, Fidelma P.
Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
title Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
title_full Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
title_fullStr Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
title_full_unstemmed Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
title_short Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
title_sort glycaemic control and novel technology management strategies in pregestational diabetes mellitus
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877346/
https://www.ncbi.nlm.nih.gov/pubmed/36714590
http://dx.doi.org/10.3389/fendo.2022.1109825
work_keys_str_mv AT newmanchristine glycaemiccontrolandnoveltechnologymanagementstrategiesinpregestationaldiabetesmellitus
AT eroadesuwa glycaemiccontrolandnoveltechnologymanagementstrategiesinpregestationaldiabetesmellitus
AT dunnefidelmap glycaemiccontrolandnoveltechnologymanagementstrategiesinpregestationaldiabetesmellitus